Nicotinic acid is a lipid-lowering agent widely used to treat hypertriglyce
ridemia and to elevate low high density lipoprotein levels. However, the un
derlying mechanisms are poorly understood. In this study, G protein activat
ion by nicotinic acid and derivatives was assessed as stimulation of guanos
ine 5'-(gamma-[S-35]-thio)triphosphate ([S-35]GTP gammaS) binding, and [H-3
]nicotinic acid was used for specific labeling of binding sites. Nicotinic
acid (EC50 similar to1 muM) stimulated [S-35]GTP gammaS binding in membrane
s from rat adipocytes and spleen, but not from other tissues. G protein act
ivation in adipocyte membranes in the presence of maximally activating conc
entrations of the selective A(1) adenosine receptor agonist 2-chloro-N-6-cy
clopentyl-adenosine and nicotinic acid was almost additive, indicating that
G proteins of mostly distinct pools were activated by these agonists. G pr
otein activation by nicotinic acid and related substances in spleen and adi
pocytes revealed identical pharmacological profiles. [H-3]Nicotinic acid sp
ecifically detected guanine nucleotide-sensitive binding sites of identical
pharmacology in adipocyte and spleen membranes. The site of action of nico
tinic acid is distinct from other G protein-coupled receptors. These data i
ndicate that nicotinic acid most probably acts on a specific G protein-coup
led receptor.